Skip to main content
Fig. 2 | Journal of Hematology & Oncology

Fig. 2

From: Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib

Fig. 2

Saracatinib suppresses Src-dependent Vimentin/Snail signaling in HNSCC cells. a The effects of saracatinib and dasatinib on the expression of EMT-related proteins. b The effects of saracatinib and dasatinib on the expression of cell tight junction-related proteins. c The effects of Src knockdown on the expression of Vimentin, E-cadherin, and Snail proteins. d Quantification of relative protein levels of Vimentin and Snail among the different treatments from three independent experiments

Back to article page